Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. 

Novo Nordisk

Western Innovation (WINN) Initiative

Pacific Economic Development Canada

Innovate BC

Stem Cell Network (SCN)

Genome British Columbia

Rhino Ventures

Pallasite Ventures

Pangaea Ventures

Radical Ventures

Tom Williams

Page One Ventures

Aspect Biosystems

2023 was a big year at Aspect! Watch our Year in Review video to see key highlights from the incredible year gone by. 

Looking forward to an exciting 2024 as we continue our mission to develop bioprinted tissue therapeutics to transform the treatment of serious diseases.

#HIRING | Vice President, Process Development & Manufacturing

We are seeking an experienced cell therapy leader with deep expertise in biopharma process development and cGMP manufacturing to join our growing team.

Learn more + apply: https://buff.ly/49tirEU 
#CellTherapy #Biotech #Biomanufacturing

Happy International Day of Women & Girls in Science! 👩‍🔬🔬 

Today, we recognize and celebrate the invaluable contributions of women in STEM globally and right here at Aspect. 

#WomenInScience #WomenInSTEM #February11

Curious what it's like to be a co-op student at Aspect? Watch the video below to hear from past co-ops about their experience with us! 🔬 💻 🧪

Looking for a co-op role for next term? We're #hiring! Kick-start your career with Aspect and contribute to our mission to transform medicine with bioprinted tissue therapeutics.   

See open roles here 👉 https://buff.ly/2z1cfay 
#AspectLife 

Bio INX is a competitor of Aspect Biosystems specializing in 3D tissue engineering and bioprinting.

Bio INX

FloatBio is a competitor of Aspect Biosystems in the field of 3D tissue engineering and bioprinting.

FloatBio

3D BIOPRINTERS is a competitor of Aspect Biosystems specializing in 3D bioprinting and tissue engineering.

3D BIOPRINTERS

Pandorum Technologies is a top competitor of Aspect Biosystems, specializing in advanced 3D bioprinting and tissue engineering technologies.

Pandorum Technologies

Next Big Innovation Labs is a top competitor of Aspect Biosystems, focusing on innovative 3D bioprinting and tissue engineering solutions.

Next Big Innovation Labs

Nano Dimension is a primary competitor of Aspect Biosystems, specializing in advanced 3D printing technologies for various applications.

Nano Dimension

3D Systems is a primary competitor of Aspect Biosystems, known for its advanced 3D printing technologies and solutions.

3D Systems

ExOne is a primary competitor of Aspect Biosystems, specializing in industrial 3D printing technologies.

ExOne

RX Networks is a top competitor of Aspect Biosystems, focusing on advanced technologies in the field of biotechnology.

RX Networks

Chrysalix is a top competitor of Aspect Biosystems, known for its investments and advancements in biotechnology and healthcare technologies.

Chrysalix

Vancouver Computer Vision is a competitor of Aspect Biosystems, specializing in computer vision technologies with potential applications in healthcare.

Vancouver Computer Vision

Aspect Biosystems is a biotechnology company that specializes in the development of 3D tissue models using microfluidics. Their technology platform is designed to enable the creation of living human tissues for drug discovery, therapeutic development, and disease modeling. The company's mission is to revolutionize how the pharmaceutical industry develops drugs by providing more predictive and high-throughput in vitro models.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 7:53 AM	4304fa64
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 14, 2024 7:53 AM	623ca5a0
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ASPECTBIOSYSTEMS

Aspect Biosystems